Warrick, Joshua I.
Knowles, Margaret A.
Hurst, Carolyn D.
Shuman, Lauren
Raman, Jay D.
Walter, Vonn
Putt, Jeffrey
Dyrskjøt, Lars
Groeneveld, Clarice
Castro, Mauro A. A.
Robertson, A. Gordon
DeGraff, David J.
Article History
Received: 14 April 2022
Accepted: 21 September 2022
First Online: 3 October 2022
Competing interests
: MK—advisory/consulting role at Janssen, QED, Loxo Oncology and Rainier Therapeutics; DJD—grant support from GlaxoSmithKlein, separate from this project; the other authors do not have competing interests.